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Crossing the Barrier: STRA6 in
Epidermal Differentiation
Kristian B. Laursen1 and Lorraine J. Gudas1
In this issue, Skazik et al. demonstrate that the STRA6 retinol transporter protein
regulates the proliferation and differentiation of epidermal keratinocytes. In
human organotypic three-dimensional skin and skin reconstitution models,
depletion of STRA6 induced hyperproliferation-associated differentiation, result-
ing in epidermal expansion. This reveals that STRA6 functions as a ‘‘gatekeeper’’ in
retinol (vitamin A)-mediated differentiation of human skin.
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The biological role of retinol
Retinol and its metabolite, all-trans reti-
noic acid (RA), are essential for embryo-
nic development (Mongan and Gudas,
2007). Humans cannot synthesize
retinol, which is consequently obtained
from the diet in the form of retinol, retinyl
esters, or beta-carotene. Mutations in
STRA6, a transmembrane retinol trans-
porter, can result in Matthew–Wood
syndrome, and impaired STRA6 func-
tion is associated with mental retarda-
tion and severe pathological phenotypes
in the eye, brain, lung, and heart
(Chassaing et al., 2013). In addition to
these roles in human disease and
development, Skazik et al. (2014) used
human skin reconstitution models to
demonstrate that STRA6 regulates retinol
homeostasis in human epidermal
keratinocytes.
Crossing the membrane
Retinol is obtained from the diet and
enters the bloodstream. Circulating reti-
nol is bound by retinol binding protein 4
(RBP4), and STRA6, an RBP4 receptor,
facilitates the transfer of retinol across
the cell membrane and delivers it to the
cellular retinol binding protein 1 (CRBP1).
After entering the cell, retinol is con-
verted into RA by oxidizing enzymes
(retinol- and retinal-dehydrogenases).
This active form of retinol enters the
nucleus, where it binds to a subtype of
nuclear receptor termed retinoic acid
receptors (RARs).
The receptors take over
Inside the cell, RA elicits a number of
responses, including transcriptional acti-
vation of numerous genes, ultimately
leading to cellular differentiation and
growth inhibition. This is achieved
by the binding of RA to heterodimers
consisting of RARs (RARa, RARb, and
RARg) and retinoid X receptors (RXRs).
The DNA-bound RARs then induce tran-
scription of target genes, including STRA6
and RARb2, which results in a positive
feedback. The transcriptional activation
of STRA6 and RARb2 in embryonic stem
cells requires RARg (Kashyap et al., 2013),
which is also the predominant RAR in
mouse keratinocytes, where it acts as a
tumor suppressor (Chen et al., 2004).
Skin squamous cell carcinoma
RA is currently being used in cancer
therapies in which a successful outcome
depends on the cancer cells’ ability to
respond to RA. The resistance of certain
cancers to RA is recapitulated in the
human prostate cancer cell line PC-3.
Normal prostate epithelial cells increase
STRA6 transcript levels in response to
retinol/RA, leading eventually to growth
arrest, whereas PC-3 tumor cells con-
tinue to proliferate (Cai and Gudas,
2009). The RA-induced growth inhibi-
tion of mouse keratinocytes requires
RARg, and ablation of RARg predisposes
keratinocytes to squamous cell car-
cinoma (Chen et al., 2004). It would be
interesting to know whether this tumor
suppressor function of RARg is related to
RARg’s ability to induce transcription of
STRA6 in certain cell types.
STRA6 facilitates retinol/RA
responsiveness in human keratinocytes
Skazik et al. (2014) started out by deter-
mining STRA6 expression and retinoid
responsiveness in normal human epi-
dermal keratinocyte (NHEK) cells. They
next used NHEK cells isolated from three
independent donors to demonstrate
that only retinol and RA (all-trans, 9-cis,
and 11-cis) consistently induced STRA6
expression. Importantly, the STRA6 in-
duction was diminished in the presence
of an RA antagonist (LE540). This argues
that STRA6 is induced through RAR/RXR
heterodimers, either directly or via other
RA target genes. Skazik et al. (2014)
found that STRA6 depletion does not
impair cellular uptake of retinol in adhe-
rent cultures of HaCaT cells. In contrast,
when HaCaT cells were used in human
organotypic three-dimensional (3D) skin
models, the STRA6-depleted conditions
resulted in a significantly thicker epi-
dermis. This was associated with an
expansion of the Krt16, Krt6, and Krt10
expression domains. These epidermal
markers, which are usually restricted to
the upper granular epidermal layer of
normal skin, were found throughout the
stratum spinosum layer of STRA6-deple-
ted skin. The expanded expression was
associated with increased proliferation of
the basal epidermal layer, evident by
elevated Ki67 expression. Importantly,
the elevated levels of Krt16 and, to
some extent, the epidermal thickening,
were reduced in retinol-supplemented
conditions. Skazik et al. (2014) further
used a human skin reconstitution model
to demonstrate that STRA6 depletion
in vivo is associated with a highly
disorganized epidermis and massive
epithelial thickening. In summary,
Skazik et al. (2014) demonstrate that in
human organotypic 3D skin and skin
reconstitution models, depletion of
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STRA6 is associated with elevated levels
of proliferation markers. The increased
proliferation could allow expansion of
the pool of progenitor cells and lead to
the observed epidermal thickening.
STRA6 in tissue regeneration
In brief, processes such as digit regene-
ration in newts and wound healing in
mammals are preceded by the genera-
tion and thickening of an epithelial
cover. Next, the underlying progenitor
cells proliferate, thereby providing a
reservoir of cells for subsequent tissue
repair. This reservoir, commonly
referred to as a blastema, is strictly
dependent on retinol at all stages of
regeneration, including cell cycle initia-
tion and differentiation. The depen-
dence on retinol points to a potential
involvement of STRA6. In keratinocytes,
STRA6 depletion results in hyperproli-
feration, which may mirror the initial
process of wound healing. Skazik et al.
(2014) observed an increased rate of
closure of scratch wounds of STRA6-
depleted HaCaT cultures as compared
with controls. Importantly, the levels of
Krt16, a marker of epidermal injury and
hyperproliferation, were elevated in
STRA6-depleted cells. Pharmacological
inhibition of STRA6 could therefore be
one approach to improve skin regenera-
tion and wound healing.
Modeling of the STRA6 protein
Successful pharmacological approaches
rely on detailed insights into the struc-
ture and the molecular mechanisms
of action of target proteins. The crystal
structure of STRA6 has yet to be deter-
mined, but unguided 3D prediction
suggests an Importin-like structure
(Figure 1). This potentially refines the
9-transmembrane-helix model, which
was proposed based on mutagenesis
and accessibility studies (Zhong et al.,
2013). The most recent study evaluated
the effects of Cys-biotin insertions to
identify two groups of key residues,
each of which is predicted to cluster
together on one site of an alpha-helical
structure (Zhong et al., 2013). A similar
arrangement is predicted by the
Importin-like model, but the helical
structures are shorter, and each helix
contains the entire group of important
residues (G290-L303 and S385-R394,
respectively). In addition, two functio-
nally important distal residues (V319,
V320) were identified (Zhong et al.,
2013). These are predicted by the
Importin-like model to have struc-
turally stabilizing positions, which
would explain their importance for
STRA6 function. The Importin-like
model further predicts that a number
of nonessential residues (V365-H384)
reside in an outward-facing region
of STRA6. Finally, all evolutionarily
divergent regions are located in loop
regions of the Importin-like STRA6
model (Figure 1). Although these points
suggest an Importin-like model, the
structure and the mechanism of action
of STRA6 will remain unclear until a
crystal structure is obtained.
Future directions
Over the past 2 years, the number of
STRA6-related papers on PubMed Cen-
tral has more than doubled. This
Clinical Implications
 Depletion of STRA6, a transmembrane retinol transporter, results in
epidermal thickening.
 Skin regeneration and wound healing could potentially be improved by
targeting STRA6.
 Pharmacologically enhancing STRA6 activity may improve cancer differ-
entiation therapies.
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Figure 1. Computational rendering: STRA6 adapts an Importin-like structure. (a) STRA6 three-
dimensional (3D) structure as predicted by unsupervised computational modeling. (b) Importin
heterodimer (rainbow and gray) occupied by Ran proteins (red and orange). (c) STRA6 3D structure for
comparison with (d) showing evolutionary divergent regions in purple. This structural prediction could
aid in refining the current 9-transmembrane-helical model, and may even suggest specific targets
for pharmacological modulation of STRA6 activity. Rainbow-colored scheme applied from the
amino- (blue) to the carboxy-terminus (red). Importin: Protein Data Bank 3EA5, predictions:
http://zhanglab.ccmb.med.umich.edu/I-TASSER/, graphics: http://www.rasmol.org/.
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increase reflects a growing interest in
the cellular uptake of retinol, an area we
are just beginning to understand. The
lack of good in vitro models and the
complexity of in vivo systems make it a
challenging task to unravel the mechan-
isms of retinol uptake. Our understand-
ing of STRA6 function was increased
significantly by recent advances in cel-
lular (Skazik et al., 2014; Zhong et al.,
2013) and biological models (Ruiz et al.,
2012; Berry et al., 2013). The generation
of STRA6-null mice provides a corner-
stone for additional biological studies.
Three independent groups generated
STRA6-null mice, and reported marked
ocular defects in them (Ruiz et al., 2012;
Berry et al., 2013). Thus, STRA6 is
essential for retinol homeostasis in the
eye. Importantly, similar ocular defects
were observed in humans harboring
mutations in STRA6 (Chassaing et al.,
2013). The reports on the STRA6-null
mice argue that STRA6 is not the only
pathway for retinol uptake (Ruiz et al.,
2012; Berry et al., 2013). This sets off a
search for additional transmembrane
retinol transporters. In this respect, it is
interesting to note that the Importin-like
model of STRA6 predicts heterodimeric
complexes (Figure 1), possibly with an
unidentified transporter. One candidate
for this protein is the recently identified
RBP4 receptor-2 (RBPR2), a protein with
40% similarity to STRA6 (Alapatt
et al., 2013). Alternatively, RBPR2 may
provide a pathway for retinol uptake
which functions independently of
STRA6 (Berry et al., 2013). Obtaining a
crystal structure of STRA6 will be a
very important step in revealing its
mechanism of action, but this must be
complemented with studies identifying
STRA6-interacting proteins.
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Calcium, Orai1, and Epidermal
Proliferation
Daniel D. Bikle1 and Theodora M. Mauro2
Ca2þ influx controls essential epidermal functions, including proliferation,
differentiation, cell migration, itch, and barrier homeostasis. The Orai1 ion channel
allows capacitive Ca2þ influx after Ca2þ release from the endoplasmic reticulum,
and it has now been shown to modulate epidermal atrophy. These findings reveal
new interactions among various Ca2þ signaling pathways and uncover novel
functions for Ca2þ signaling via the Orai1 channel.
Journal of Investigative Dermatology (2014) 134, 1506–1508; doi:10.1038/jid.2014.54
Epidermal Ca2þ has long been recog-
nized as an essential signal for many
epidermal functions. Beginning with
early descriptions of the keratinocyte
differentiation response, changes in
extracellular and intracellular Ca2þ
have been shown to direct keratinocyte
proliferation, differentiation, and barrier
homeostasis (reviewed in Mascia et al.
(2012)). The marked Ca2þ gradient
present in the epidermis, almost 4-fold
higher in the stratum granulosum than
in the basal layer, suggests that Ca2þ
signaling seen in the culture dish is
reflected in the in vivo responses of
the epidermis. This report, ‘‘Reversal of
Murine Epidermal Atrophy by Topical
Modulation of Calcium Signaling’’,
by Darbellay et al. (2014) reveals
that Ca2þ flux through the plasma
membrane Orai1 channel additionally
controls epidermal proliferation and
thickness, particularly when the epi-
dermis atrophies in response to aging
or chronic corticosteroid topical appli-
cation. Related recent reports demon-
strate further that the Orai1 channel also
controls keratinocyte focal adhesion
turnover (Vandenberghe et al., 2013)
and modulates early aspects of keratino-
cyte differentiation (Numaga-Tomita
and Putney, 2013).
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